Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | KMO | O15229 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | THPO | P40225 | 1/20 | 0.40 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.40 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.39 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urea SCHEMBL2190324 | 0.90 | KMO (0.51) | RECQLKMOCYP1A2DDB1CRBN | |
| Carbamic Acid SCHEMBL1857014 | 0.88 | KMO (0.54) | RECQLKMOCYP1A2DDB1CRBN | |
| SCHEMBL276288 | 0.73 | RECQL (0.48) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL9123802 | 0.73 | ELANE (0.49) | RECQLKMOCYP1A2CYP11B1CYP11B2 | |
| SCHEMBL787026 | 0.71 | RECQL (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL61456 | 0.71 | RECQL (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL2010731 | 0.71 | RECQL (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL329140 | 0.71 | RECQL (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL47226 | 0.71 | CYP1A2 (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT | |
| SCHEMBL13647386 | 0.71 | RECQL (0.47) | RECQLKMOCYP1A2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1033 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080001-A | Perfluoroalkyl substituted pyrimido [1,2-b ] indazole ketone compound and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-20260076943-A1 | METHOD FOR IMPROVING SKELETAL HEALTH | UNIV INDIANA TRUSTEES (US) | 2026-03-19 | — | — | US | claimed |
| US-20250277156-A1 | USE AND METHOD | INNOSPEC LIMITED (GB) | 2025-09-04 | — | — | US | claimed |
| US-20250270463-A1 | USE AND METHOD | INNOSPEC LIMITED (GB) | 2025-08-28 | — | — | US | claimed |
| CN-116063283-B | 3-Amino indazole compound and application thereof | 暨南大学 | 2025-03-25 | — | — | CN | claimed |
| EP-4514924-A1 | USE AND METHOD | Innospec Limited (GB) | 2025-03-05 | — | — | EP | claimed |
| EP-4514925-A1 | USE AND METHOD | Innospec Limited (GB) | 2025-03-05 | — | — | EP | claimed |
| CN-118994101-A | Arylindazole ring compound, preparation method, pharmaceutical composition and application | 安徽医科大学 | 2024-11-22 | — | — | CN | claimed |
| WO-2023209370-A1 | USE AND METHOD | INNOSPEC LIMITED (GB) | 2023-11-02 | — | — | WO | claimed |
| WO-2023209369-A1 | USE AND METHOD | INNOSPEC LIMITED (GB) | 2023-11-02 | — | — | WO | claimed |
| EP-0904769-B1 | Keratin fibre dye compositions containing Indazole amine derivatives and dyeing method | OREAL (FR) | 2002-09-25 | — | — | EP | claimed |
| US-20020040508-A1 | COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE | L'OREAL S.A. (FR) | 2002-04-11 | — | — | US | claimed |
| WO-2001078648-A2 | 6-METHYLNICOTINAMIDE DERIVATIVES AS ANTIVIRAL AGENTS | DONG WHA PHARM. IND. CO., LTD. (KR) | 2001-10-25 | — | — | WO | claimed |
| EP-0981320-A1 | COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE | L'OREAL (FR) | 2000-03-01 | — | — | EP | claimed |
| WO-1998051268-A1 | COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE | L'OREAL (FR) | 1998-11-19 | — | — | WO | claimed |
| EP-0848613-A1 | ANALOGS FOR SPECIFIC OLIGOSACCHARIDE-NEUREGULIN INTERACTIONS AND USES THEREOF | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1998-06-24 | — | — | EP | claimed |
| WO-1997009051-A1 | ANALOGS FOR SPECIFIC OLIGOSACCHARIDE-NEUREGULIN INTERACTIONS AND USES THEREOF | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1997-03-13 | — | — | WO | claimed |
| WO-1992000981-A1 | NOVEL 3-SUBSTITUTED CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF | DAE WOONG PHARMACEUTICAL CO., LTD. (KR) | 1992-01-23 | — | — | WO | claimed |
| US-5017471-A | Reagent for peroxidase detection | EPITOPE, INC. (US) | 1991-05-21 | — | — | US | claimed |
| US-4999267-A | ELECTROGRAPHY | MINOLTA CAMERA KABUSHIKI KAISHA (JP) | 1991-03-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040508-A1 | COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE | KRT18, KLK5, H1-5 | RECQL 1620/4885KMO 47/4885CYP1A2 174/4885 |
| US-20260076943-A1 | METHOD FOR IMPROVING SKELETAL HEALTH | MYOF, CKMT1A; CKMT1B, MUSK | RECQL 4329/4885KMO 71/4885CYP1A2 2928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.